|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Sales | |||||
| COST OF REVENUES | |||||
| Cost of Goods Sold | |||||
| Gross Profit (Loss) | |||||
| Operating expenses: | |||||
| Advertising | |||||
| General and administrative | |||||
| Officers, annual salary | |||||
| Depreciation and amortization | |||||
| Office Rent | |||||
| Non cash management fees | |||||
| Sales commissions | |||||
| Consulting | |||||
| Legal and professional | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Commission income | |||||
| Gain on disposal of Resonate Blends | |||||
| Gain (loss) on investment | |||||
| Other income | |||||
| Gain (loss) on change in derivative liability | |||||
| Amortization of issuance costs | |||||
| Gain (loss) on conversion of debt | |||||
| Gain (loss) on settlement of notes payable | |||||
| Total other income (expense) | |||||
| NET INCOME (LOSS) from continuing operations | |||||
| Net loss | |||||
| Net loss per share - basic | |||||
| Net loss per share - diluted | |||||
| Weighted average shares outstanding - basic | |||||
Loading...